Form D · Biotechnology
Metallomix, Inc
Miami, FL · CIK 0001894153
Offering snapshot reported Nov 10, 2025 · SEC filing
- Reported sold
- $1.16M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- Oct 18, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2025 | Initial | $1,158,060 | No comparison | 1 | SEC filing |
| Sep 11, 2023 | Initial | $534,200 | No comparison | 1 | SEC filing |
| May 23, 2022 | Amendment | $300,000 | $0vs Nov 26, 2021 | 1 | SEC filing |
| Nov 26, 2021 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Nov 17, 2021 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-563592
Source: Form D, filed Nov 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sergey Gurin | Director, Executive |
| Sergei Petukhov | Director, Executive |
| Max Temnik | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
175 Sw 7 Th St Suite 1702
Miami, FL, 33130
Miami, FL, 33130